To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FOXL2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
38 supporting clones for gene FOXL2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BC062549 Pancreas, epithelioid carcinoma .a-u 1 to 2329 1 to 2329 exact tiling clone, available from MGC,   2329/2334
(99 %)
1 diff
(100.0 %id)
NM_023067.3   .a-u 1 to 2917 1 to 2917 exact RefSeq,   2917/2917
(100 %)
0 diff
(100 %id)
BU540786 epithelioid carcinoma cell line, Pancreas .a-u 2 to 617 1 to 618       618/994
(62 %)
17 diff
(98.3 %id)
BQ227945 epithelioid carcinoma, Pancreas .a-u 38 to 620 12 to 600       589/990
(59 %)
10 diff
(99.0 %id)
AF301906   .a-u 182 to 2915 1 to 2734 exact AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2734/2734
(100 %)
9 diff
(99.7 %id)
DQ089670   .a-u 182 to 2915 1 to 2764 G235A P236A G237A S238A P239A ... AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2764/2764
(100 %)
10 diff
(99.7 %id)
DQ089671   .a-u 182 to 2915 1 to 2733 P239L G240A A241R A242P A243L ... AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2733/2733
(100 %)
10 diff
(99.7 %id)
DQ089672   .a-u 182 to 2915 1 to 2734 Q219* AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2734/2734
(100 %)
10 diff
(99.7 %id)
FJ598614   .a-u 182 to 2915 1 to 2733 P239L G240A A241R A242P A243L ... AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2733/2733
(100 %)
11 diff
(99.6 %id)
BC019896 Cervix, carcinoma .a-u 254 to 1138 1 to 885   available from MGC,   885/885
(100 %)
1 diff
(99.9 %id)
BI254526 cervical carcinoma cell line, cervix .a-u 254 to 1082 1 to 838   available from MGC,   838/842
(99 %)
17 diff
(98.0 %id)
BF194985 fibrotheoma, ovary .a-u 590 to 1099 510 to 1       510/510
(100 %)
0 diff
(100 %id)
BF195667 fibrotheoma, ovary .a-u 605 to 1106 502 to 1       502/502
(100 %)
1 diff
(99.9 %id)
BF221724 pooled .a-u 680 to 1146 467 to 1       467/467
(100 %)
21 diff
(95.6 %id)
BF058300 fibrotheoma, ovary .a-u 1319 to 1836 1 to 518     Submitted on the opposite strand 518/518
(100 %)
0 diff
(100 %id)
BF116062 fibrotheoma, ovary .a-u 1319 to 1900 1 to 582     Submitted on the opposite strand 582/582
(100 %)
0 diff
(100 %id)
BF116260 fibrotheoma, ovary .a-u 1319 to 1738 1 to 420     Submitted on the opposite strand 420/420
(100 %)
12 diff
(97.2 %id)
AW298364   .a-u 1320 to 1773 1 to 454     Submitted on the opposite strand 454/454
(100 %)
0 diff
(100 %id)
BF514546   .a-u 1320 to 1802 1 to 483     Submitted on the opposite strand 483/483
(100 %)
1 diff
(99.8 %id)
BF435066 fibrotheoma, ovary .a-u 1328 to 1887 1 to 560     Submitted on the opposite strand 560/564
(99 %)
1 diff
(99.9 %id)
BF434043 fibrotheoma, ovary .a-u 1369 to 1888 1 to 520     Submitted on the opposite strand 520/520
(100 %)
0 diff
(100 %id)
AA088637 uterus .a-u 1524 to 1959 3 to 441       439/442
(99 %)
6 diff
(98.7 %id)
BF513496   .a-u 1781 to 2316 553 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 536/536
(100 %)
0 diff
(100 %id)
AA088215 uterus .a-u 2108 to 2316 204 to 1       204/204
(100 %)
7 diff
(96.6 %id)
BF683120 leiomyosarcoma cell line, uterus .a-u 2161 to 2572 1 to 417       417/417
(100 %)
21 diff
(95.0 %id)
BF507370   .a-u 2171 to 2316 163 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 146/148
(98 %)
2 diff
(98.7 %id)
BF512825   .a-u 2239 to 2316 95 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 78/88
(88 %)
0 diff
(100 %id)
BF515406   .a-u 2300 to 2795 13 to 508   tiling clone, Submitted on the opposite strand 496/508
(97 %)
9 diff
(98.3 %id)
BX095729 uterus .a-u 2384 to 2915 1 to 532   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 532/532
(100 %)
0 diff
(100 %id)
AA128030 uterus .a-u 2384 to 2852 1 to 471       471/471
(100 %)
5 diff
(99.0 %id)
AA128061 uterus .a-u 2384 to 2915 15 to 557   fully sequenced,   543/557
(97 %)
16 diff
(97.2 %id)
AA156761 uterus .a-u 2384 to 2910 1 to 518   fully sequenced,   518/518
(100 %)
8 diff
(98.5 %id)
AI140383 heart .a-u 2455 to 2916 463 to 1   tiling clone,   463/463
(100 %)
1 diff
(99.8 %id)
AA128018 uterus .a-u 2461 to 2915 470 to 1   fully sequenced,   470/470
(100 %)
20 diff
(95.8 %id)
AI370750 uterus .a-u 2485 to 2915 431 to 1       431/431
(100 %)
0 diff
(100 %id)
AI887435 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a-u 2511 to 2915 405 to 1       405/405
(100 %)
0 diff
(100 %id)
AI224168 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a-u 2524 to 2915 392 to 1       392/392
(100 %)
1 diff
(99.8 %id)
AI089172 pooled .a-u 2553 to 2915 372 to 11   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 362/362
(100 %)
2 diff
(99.5 %id)
AA156960 uterus .a-u 2770 to 2915 144 to 1   fully sequenced,   144/144
(100 %)
0 diff
(100 %id)
BF512713   Gene FOXL2, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BE857462 brain, glioblastoma (pooled) Gene FOXL2, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
? Gene Summary Gene on genome mRNA Expression Tissue Function, regulation, related genes DCI